Incyte Genomics
INCY
NASDAQ
IPO1993
about INCY
Incyte Genomics is a biopharmaceutical company focused on advancing innovative cancer treatments through precision medicine and oncology research, offering targeted therapies for patients with serious diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $95.76 | $96.00 | $93.54 | $18.9B | 2.26M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$2.17 | 17.38 | 14.07 | 32.47% | 31.05% | 0% |